{"guideline_source":"2020 FOCUSED UPDATES TO THE Asthma Management Guidelines","recommendation_summary":"For children aged 0-4 years with persistent asthma, the preferred treatment is daily low-dose inhaled corticosteroids (ICS) with as-needed short-acting beta-agonists (SABA). If symptoms are not adequately controlled, consider stepping up to medium-dose ICS. Regular assessment of control, adherence, inhaler technique, and environmental factors is essential. Step down therapy if asthma is well controlled for at least 3 consecutive months.","reference_section":"Figure I.b: Stepwise Approach for Management of Asthma in Individuals Ages 0–4 Years"}
{"guideline_source":"Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies","recommendation_summary":"For patients with atopic dermatitis refractory to topical therapies, consider treatment with phototherapy and systemic therapies. Multiple biologic therapies and Janus kinase (JAK) inhibitors have been approved since 2014 for the treatment of atopic dermatitis. These therapies should be considered based on individual patient circumstances and disease severity.","reference_section":"Background and Objective sections"}
